EHS – Page 16 – Pharma.Tips

Test article accountability issue during study reconstruction – evidence package inspectors expect

Addressing Test Article Accountability Issues During Study Reconstruction: An Actionable Playbook In today’s highly regulated pharmaceutical landscape, maintaining accountability for test articles throughout the study reconstruction process is critical. Failure…

Deviation handling weak during regulatory inspection – evidence package inspectors expect

Addressing Weaknesses in Deviation Handling for Regulatory Inspections In the highly regulated pharmaceutical landscape, managing deviations efficiently is crucial for compliance and product quality. Weak deviation handling during regulatory inspections…

Analyst training deficiency during sponsor oversight – CAPA for GLP system gaps

Addressing Analyst Training Gaps During Sponsor Oversight in GLP Settings In the pharmaceutical and biotechnology sectors, the importance of adequate analyst training cannot be overstated. Insufficient training during sponsor oversight…

Test article accountability issue during study reconstruction – alignment with OECD principles

Addressing Test Article Accountability Issues during Study Reconstruction In the complex landscape of pharmaceutical manufacturing and quality assurance, ensuring test article accountability during study reconstruction is critical. Any gaps can…

Deviation handling weak during study reconstruction – preventing repeat GLP findings

Strategies to Address Weaknesses in Deviation Handling During Study Reconstruction In the realm of pharmaceutical manufacturing and laboratory practices, the handling of deviations during study reconstruction is crucial to maintaining…

Raw data traceability failure during regulatory inspection – CAPA for GLP system gaps

Addressing Raw Data Traceability Failures in Regulatory Inspections In the tightly regulated environment of pharmaceutical development and manufacturing, raw data traceability is essential for compliance with Good Laboratory Practice (GLP)…

GLP study documentation gaps during study reconstruction – evidence package inspectors expect

Addressing GLP Study Documentation Gaps During Reconstruction for Inspection Readiness In pharmaceutical manufacturing and quality assurance, ensuring your Good Laboratory Practice (GLP) compliance is of paramount importance, especially during study…

Deviation handling weak during routine studies – preventing repeat GLP findings

Improving Deviation Handling during Routine GLP Studies In the pharmaceutical sector, particularly within laboratories adhering to Good Laboratory Practices (GLP), deviations from established protocols can ignite complex challenges, potentially leading…

Tag: EHS

Test article accountability issue during study reconstruction – evidence package inspectors expect

Deviation handling weak during regulatory inspection – evidence package inspectors expect

Analyst training deficiency during sponsor oversight – CAPA for GLP system gaps

Test article accountability issue during study reconstruction – alignment with OECD principles

Deviation handling weak during study reconstruction – preventing repeat GLP findings

Raw data traceability failure during regulatory inspection – CAPA for GLP system gaps

GLP study documentation gaps during study reconstruction – evidence package inspectors expect

Deviation handling weak during routine studies – preventing repeat GLP findings

Raw data traceability failure during regulatory inspection – preventing repeat GLP findings

GLP study documentation gaps during sponsor oversight – inspection deficiency risk analysis

Raw data traceability failure during sponsor oversight – CAPA for GLP system gaps

Analyst training deficiency during sponsor oversight – evidence package inspectors expect